The NF-κB (p65) signaling pathway is vital for promoting cell survival, particularly in RAS-driven cancers [22]. Where increased RAL, ERK, and AKT activation occurs even without RAS mutation [23]. This evidence concerns the gene NFKB1 and cancer.